# Genesis RNA: Research Workflow for Cancer Cure

This document outlines a complete research workflow for using Genesis RNA to contribute to cancer research and therapeutics development.

## üéØ Mission

Use AI-powered RNA modeling to:
1. **Predict** which genetic variants cause cancer (variant pathogenicity)
2. **Design** RNA-based therapeutics (mRNA vaccines, gene therapy)
3. **Discover** personalized cancer treatments (neoantigens)
4. **Accelerate** drug discovery and development

---

## üìã Table of Contents

1. [Quick Start](#quick-start)
2. [Phase 1: Foundation Model Training](#phase-1-foundation-model-training)
3. [Phase 2: Cancer-Specific Fine-Tuning](#phase-2-cancer-specific-fine-tuning)
4. [Phase 3: Clinical Validation](#phase-3-clinical-validation)
5. [Phase 4: Therapeutic Design](#phase-4-therapeutic-design)
6. [Phase 5: Publication & Impact](#phase-5-publication--impact)

---

## Quick Start

### Prerequisites

```bash
# Install dependencies
pip install -r requirements.txt

# Verify GPU availability (recommended)
python -c "import torch; print(f'CUDA available: {torch.cuda.is_available()}')"
```

### 1. Generate Training Data

```bash
# Generate realistic ncRNA sequences (5,000 samples)
cd genesis_rna/scripts
python generate_sample_ncrna.py --output ../../data/human_ncrna --num_samples 5000

# Download BRCA variant data
cd ../..
python scripts/download_brca_variants.py --output data/breast_cancer/brca_mutations
```

### 2. Train Foundation Model

```bash
# Train on ncRNA data (~30 min on GPU)
python -m genesis_rna.train_pretrain \
    --data_path data/human_ncrna \
    --model_size base \
    --batch_size 32 \
    --num_epochs 10 \
    --output_dir checkpoints/pretrained/base
```

### 3. Evaluate on Cancer Variants

```bash
# Split data into train/test
python scripts/split_dataset.py \
    --input data/breast_cancer/brca_mutations/train.jsonl \
    --train_out data/breast_cancer/train.jsonl \
    --test_out data/breast_cancer/test.jsonl \
    --test_split 0.2

# Evaluate
python scripts/evaluate_cancer_model.py \
    --model checkpoints/pretrained/base/best_model.pt \
    --test_data data/breast_cancer/test.jsonl
```

---

## Phase 1: Foundation Model Training

### Goal
Train a foundational RNA language model that understands RNA structure, function, and evolution.

### Data Sources

#### Option A: Sample Data (Quick Start)
```bash
# Generate 5K synthetic ncRNA sequences
python genesis_rna/scripts/generate_sample_ncrna.py \
    --num_samples 5000 \
    --output data/human_ncrna
```

**Pros**: Fast, no downloads, good for testing
**Cons**: Limited diversity, may not generalize well

#### Option B: Real ncRNA Database (Recommended)
```bash
# Download from RNAcentral (requires ~5GB space)
# TODO: Implement RNAcentral downloader
python scripts/download_rnacentral.py --output data/rnacentral
```

**Pros**: Real data, broad coverage, better generalization
**Cons**: Large download, needs preprocessing

#### Option C: Full TCGA Cancer RNA-seq (Advanced)
```bash
# List available TCGA breast cancer data
python scripts/download_tcga_data.py --list --cancer_type BRCA

# Download (requires dbGaP authorization for raw data)
python scripts/download_tcga_data.py \
    --download \
    --cancer_type BRCA \
    --max_files 100 \
    --output data/tcga/brca
```

**Pros**: Real cancer patient data, clinically relevant
**Cons**: Requires authorization, large files

### Training

```bash
# Train on real data
python -m genesis_rna.train_pretrain \
    --data_path data/human_ncrna \
    --model_size base \
    --d_model 512 \
    --n_layers 8 \
    --n_heads 8 \
    --batch_size 32 \
    --num_epochs 20 \
    --learning_rate 1e-4 \
    --use_ast \
    --output_dir checkpoints/pretrained/base

# Monitor training
tensorboard --logdir checkpoints/pretrained/base/logs
```

### Expected Results
- **Training time**: ~2-4 hours on GPU (V100/A100)
- **MLM accuracy**: >85% (masked language modeling)
- **Structure prediction**: >70% accuracy
- **Validation loss**: <0.5

---

## Phase 2: Cancer-Specific Fine-Tuning

### Goal
Specialize the foundation model for cancer variant prediction.

### Data Preparation

#### Get BRCA Variants

```bash
# Option 1: Synthetic data (expanded, realistic)
python scripts/download_brca_variants.py \
    --output data/breast_cancer/brca_mutations \
    --genes BRCA1 BRCA2

# Option 2: Real ClinVar data (requires BioPython)
pip install biopython
python scripts/download_brca_variants.py \
    --output data/breast_cancer/brca_mutations \
    --genes BRCA1 BRCA2 \
    --use_real_api \
    --email your@email.com
```

**Real ClinVar gives you**:
- 1,000+ annotated BRCA1 variants
- 1,000+ annotated BRCA2 variants
- Clinical significance labels (Pathogenic/Benign/VUS)
- Review status and evidence levels

### Fine-Tuning

```bash
# Fine-tune on BRCA variants
python -m genesis_rna.train_finetune \
    --task mutation_effect \
    --pretrained_model checkpoints/pretrained/base/best_model.pt \
    --train_data data/breast_cancer/train.jsonl \
    --val_data data/breast_cancer/val.jsonl \
    --output_dir checkpoints/finetuned/brca_mutations \
    --batch_size 16 \
    --num_epochs 20 \
    --learning_rate 1e-5
```

### Expected Results
- **AUC-ROC**: >0.85 (goal: >0.90 for clinical use)
- **Sensitivity**: >0.90 (minimize false negatives)
- **Specificity**: >0.85 (minimize false positives)

---

## Phase 3: Clinical Validation

### Goal
Validate predictions against clinical gold standards and benchmark against existing tools.

### Evaluation

```bash
# Comprehensive evaluation
python scripts/evaluate_cancer_model.py \
    --model checkpoints/finetuned/brca_mutations/best_model.pt \
    --test_data data/breast_cancer/test.jsonl \
    --output results/evaluation_metrics.json
```

### Benchmarking

Compare Genesis RNA against:
1. **PolyPhen-2**: Protein variant prediction
2. **SIFT**: Sorting Intolerant From Tolerant
3. **EVE**: Evolutionary model of Variant Effect
4. **AlphaMissense**: DeepMind's variant predictor

```python
# Example comparison
import json

# Load Genesis RNA results
with open('results/evaluation_metrics.json') as f:
    genesis_results = json.load(f)

print(f"Genesis RNA AUC-ROC: {genesis_results['auc_roc']:.3f}")
print(f"PolyPhen-2 AUC-ROC:  0.82  (typical)")
print(f"EVE AUC-ROC:         0.84  (typical)")
```

### Clinical Interpretation

**For Genetic Counseling**:
- Sensitivity >95%: Safe for clinical screening
- Specificity >90%: Low false positive rate
- PPV >85%: High confidence in pathogenic calls

**VUS Reclassification**:
- Goal: Classify 30-50% of VUS as likely pathogenic/benign
- Reduces uncertainty for patients and clinicians

---

## Phase 4: Therapeutic Design

### Goal
Use the trained model to design RNA-based cancer therapeutics.

### A. mRNA Cancer Therapeutics

```python
from genesis_rna.breast_cancer import mRNATherapeuticDesigner
from genesis_rna import GenesisRNAModel

# Load model
model = GenesisRNAModel.from_pretrained('checkpoints/pretrained/base/best_model.pt')
designer = mRNATherapeuticDesigner(model)

# Design p53 tumor suppressor mRNA
p53_protein = "MEEPQSDPSVEPPLSQETFSDLWKLLPENNVL..."  # Full sequence

therapeutic = designer.design(
    protein_sequence=p53_protein,
    optimization_goals={
        'stability': 0.95,
        'translation': 0.90,
        'immunogenicity': 0.05
    }
)

print(f"Designed therapeutic mRNA:")
print(f"  Length: {len(therapeutic.sequence)} nt")
print(f"  Stability score: {therapeutic.stability_score:.3f}")
print(f"  Predicted half-life: {therapeutic.half_life_hours:.1f} hours")
```

**Use Cases**:
- Tumor suppressor delivery (p53, BRCA1)
- Oncogene silencing (HER2 siRNA)
- Immune activation (cytokines)

### B. Personalized Cancer Vaccines

```python
from genesis_rna.breast_cancer import NeoantigenDiscovery

# Analyze patient tumor RNA-seq
discoverer = NeoantigenDiscovery(model)

# Find tumor-specific neoantigens
neoantigens = discoverer.find_neoantigens(
    tumor_sequences=patient_tumor_rna,
    normal_sequences=patient_normal_rna,
    hla_type="HLA-A*02:01"
)

# Design personalized vaccine
vaccine_mrna = discoverer.design_vaccine(
    neoantigens=neoantigens[:10],  # Top 10
    adjuvant="lipid_nanoparticle"
)

print(f"Discovered {len(neoantigens)} neoantigens")
print(f"Vaccine mRNA designed: {len(vaccine_mrna)} nt")
```

### C. Drug Target Discovery

```python
from genesis_rna.breast_cancer import BreastCancerAnalyzer

# Screen gene variants for druggability
analyzer = BreastCancerAnalyzer('checkpoints/finetuned/brca_mutations/best_model.pt')

# Analyze multiple genes
cancer_genes = ['TP53', 'HER2', 'PIK3CA', 'PTEN', 'CDH1']

for gene in cancer_genes:
    # Analyze common variants
    prediction = analyzer.predict_variant_effect(
        gene=gene,
        wild_type_rna=wt_sequence,
        mutant_rna=mut_sequence
    )

    if prediction.pathogenicity_score > 0.8:
        print(f"{gene}: High-priority therapeutic target")
```

---

## Phase 5: Publication & Impact

### Goal
Share findings with the research community and accelerate cancer cure research.

### A. Prepare Manuscript

**Key Results to Report**:
1. Model architecture and training
2. Variant prediction performance (AUC-ROC, sensitivity, specificity)
3. VUS reclassification results
4. Comparison with existing methods
5. Case studies (specific BRCA variants)
6. Therapeutic design examples

**Suggested Journals**:
- Nature Medicine
- Nature Biotechnology
- Cell
- Science Translational Medicine
- PLOS Computational Biology

### B. Share Code & Data

```bash
# Prepare reproducible research package
mkdir -p publication/
cp -r genesis_rna/ publication/code/
cp -r data/ publication/data/  # Exclude large files
cp -r results/ publication/results/

# Create comprehensive README
cat > publication/README.md << EOF
# Genesis RNA: AI for Cancer Variant Prediction

Reproducible code for: "Deep Learning for BRCA Variant Pathogenicity Prediction"

## Quick Start
1. Install: pip install -r requirements.txt
2. Download data: python scripts/download_brca_variants.py
3. Train model: python -m genesis_rna.train_pretrain
4. Evaluate: python scripts/evaluate_cancer_model.py

## Citation
[Add BibTeX]
EOF
```

### C. Open Source Release

```bash
# Tag release
git tag -a v1.0.0 -m "First release: BRCA variant prediction"
git push origin v1.0.0

# Create GitHub release
# Add:
# - Pre-trained model weights
# - Example notebooks
# - Documentation
# - License (MIT/Apache 2.0)
```

### D. Clinical Translation

**Partner with**:
- **Genetic testing labs**: Integrate into clinical workflows
- **Cancer centers**: Validate on patient cohorts
- **Biotech companies**: Develop therapeutics
- **Regulatory agencies**: Seek FDA/EMA approval for clinical use

---

## üöÄ Advanced Topics

### Scaling Up

#### Multi-GPU Training
```bash
# Train on 4 GPUs
python -m torch.distributed.launch \
    --nproc_per_node=4 \
    -m genesis_rna.train_pretrain \
    --data_path data/human_ncrna \
    --batch_size 128 \
    --num_epochs 50
```

#### Large-Scale Data
```bash
# Train on millions of sequences
# 1. Download full RNAcentral database
# 2. Preprocess and shard data
# 3. Use data loading pipeline with prefetching
```

### Transfer Learning

```bash
# Pre-train on general RNA
python -m genesis_rna.train_pretrain --data_path data/rnacentral

# Fine-tune on cancer-specific data
python -m genesis_rna.train_finetune --task breast_cancer

# Further fine-tune on other cancers
python -m genesis_rna.train_finetune --task lung_cancer
```

---

## üìä Expected Timeline

### Rapid Research Track (1-2 months)
- Week 1-2: Train foundation model on sample data
- Week 3-4: Fine-tune on BRCA variants
- Week 5-6: Evaluate and benchmark
- Week 7-8: Write manuscript, prepare code release

### Comprehensive Research Track (6-12 months)
- Month 1-2: Train on full RNAcentral database
- Month 3-4: Fine-tune on multiple cancer types
- Month 5-6: Clinical validation on patient cohorts
- Month 7-9: Therapeutic design and validation
- Month 10-12: Publication, clinical translation

---

## üéØ Success Metrics

### Scientific Impact
- [ ] AUC-ROC >0.90 for variant prediction
- [ ] Reclassify >30% of VUS with confidence
- [ ] Outperform existing methods (PolyPhen, SIFT, EVE)
- [ ] Publish in high-impact journal (Nature/Science/Cell)

### Clinical Impact
- [ ] Integrate into clinical genetic testing workflows
- [ ] Improve patient risk assessment
- [ ] Guide treatment decisions
- [ ] Reduce unnecessary interventions

### Therapeutic Impact
- [ ] Design >10 novel mRNA therapeutics
- [ ] Validate in cell culture
- [ ] Partner with biotech for development
- [ ] Advance to clinical trials

---

## üÜò Troubleshooting

### Common Issues

**Out of Memory**:
```bash
# Reduce batch size
--batch_size 16

# Use gradient accumulation
--gradient_accumulation_steps 4

# Use mixed precision
--fp16
```

**Low Performance**:
- Train longer (more epochs)
- Use more data (download real datasets)
- Increase model size
- Adjust learning rate

**Can't Download TCGA**:
- Start with synthetic/ClinVar data
- Apply for dbGaP access for raw sequencing data
- Use GDC Data Transfer Tool for large downloads

---

## üìö Resources

### Databases
- **ClinVar**: https://www.ncbi.nlm.nih.gov/clinvar/
- **TCGA**: https://portal.gdc.cancer.gov/
- **COSMIC**: https://cancer.sanger.ac.uk/cosmic
- **RNAcentral**: https://rnacentral.org/

### Tools
- **GDC Transfer Tool**: https://gdc.cancer.gov/access-data/gdc-data-transfer-tool
- **VEP**: Variant Effect Predictor
- **PolyPhen-2**: http://genetics.bwh.harvard.edu/pph2/

### Papers
- TCGA Nature 2012: https://doi.org/10.1038/nature11412
- AlphaFold in Nature: https://doi.org/10.1038/s41586-021-03819-2
- RNA Therapeutics Review: Nature Reviews Drug Discovery

---

## ü§ù Contributing

This is open science! Contributions welcome:
- New data sources
- Model improvements
- Evaluation metrics
- Clinical validation studies
- Bug fixes and documentation

See `CONTRIBUTING.md` for guidelines.

---

## üìß Support

- **Issues**: GitHub Issues
- **Email**: [Your contact]
- **Slack/Discord**: [Community link]

---

## üèÜ Mission Statement

**We're building AI tools to cure cancer.**

Every variant we classify correctly helps a patient.
Every therapeutic we design could save lives.
Every insight we share accelerates the field.

Let's work together to make cancer a curable disease.

---

*Last updated: 2025-11*
*Version: 1.0*
